Browsing by Author "Simuni, Tanya"
Now showing items 1-4 of 4
-
Application of Longitudinal Item Response Theory Models to Modeling Parkinson's Disease Progression.
Zou, Haotian; Aggarwal, Varun; Stebbins, Glenn T; Müller, Martijn LTM; Cedarbaum, Jesse M; Pedata, Anne; Stephenson, Diane; ... (9 authors) (CPT: pharmacometrics & systems pharmacology, 2022-07-27)The Movement Disorder Society revised version of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Parts 2 and 3 reflect patient-reported functional impact and clinician-reported severity of motor signs of Parkinson's ... -
Dissecting the Domains of Parkinson's Disease: Insights from Longitudinal Item Response Theory Modeling.
Luo, Sheng; Zou, Haotian; Stebbins, Glenn T; Schwarzschild, Michael A; Macklin, Eric A; Chan, James; Oakes, David; ... (10 authors) (Movement disorders : official journal of the Movement Disorder Society, 2022-09)<h4>Background</h4>Longitudinal item response theory (IRT) models previously suggested that the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) motor examination has two salient domains, tremor ... -
Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus.
Black, Kevin J; Nasrallah, Henry; Isaacson, Stuart; Stacy, Mark; Pahwa, Rajesh; Adler, Charles H; Alva, Gustavo; ... (15 authors) (CNS spectrums, 2018-12)Patients with Parkinson's disease psychosis (PDP) are often treated with an atypical antipsychotic, especially quetiapine or clozapine, but side effects, lack of sufficient efficacy, or both may motivate a switch to pimavanserin, ... -
Novel Approach to Movement Disorder Society–Unified Parkinson's Disease Rating Scale Monitoring in Clinical Trials: Longitudinal Item Response Theory Models
Luo, Sheng; Zou, Haotian; Goetz, Christopher G; Choi, Dongrak; Oakes, David; Simuni, Tanya; Stebbins, Glenn T (Movement Disorders Clinical Practice, 2021-01-01)Background: Although nontremor and tremor Part 3 Movement Disorder Society–Unified Parkinson's Disease Rating Scale items measure different impairment domains, their distinct progression and drug responsivity remain unstudied ...